Intranasal Therapeutics, Inc.
Intranasal Therapeutics Names Jeffrey Edelson, MD, Executive Vice President, R&D and Chief Medical Officer
Published in Hematology Week, July 21st, 2008
Intranasal Therapeutics, Inc. (ITI), a specialty pharmaceutical company focused on developing nasally delivered, preservative-free drug products, announced a key executive addition to the company's leadership team. Jeff Edelson, MD, previously employed by Johnson & Johnson (J&J) as Vice President, Internal Medicine and Therapeutic Area Head - Novel Therapeutics, has joined ITI as Executive Vice President, R&D, and Chief Medical Officer.
"We are delighted to have someone of Jeff's caliber as a member of the ITI management team," said Peter F. Young, President and Chief Executive Officer of ITI. "Jeff is a highly experienced product development and clinical research...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2008-07-21)
More Articles from Hematology Week
- JAMA and Archives Journals
Index used to predict atherosclerosis may improve accuracy of cardiovascular risk prediction - Salk Institute
Can you hear me now? - University of Oregon
Members of consumer-driven health plans choosing less care - Attention Deficit Hyperactivity Disorder
Head-to-head study demonstrates Focalin® XR offers faster and better symptom control than Concerta® in early part of ADHD patients day - Autoimmune Hemolytic Anemia
Study findings from University of Connecticut broaden understanding of autoimmune hemolytic anemia - Bipolar Disorder
Scientists at Tampere University target bipolar disorder - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
